BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22123235)

  • 1. Metabolic diseases and cancer risk.
    Faulds MH; Dahlman-Wright K
    Curr Opin Oncol; 2012 Jan; 24(1):58-61. PubMed ID: 22123235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy balance, physical activity, and cancer risk.
    Fair AM; Montgomery K
    Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlations of insulin resistance and neoplasms].
    Suba Z; UjpƔl M
    Magy Onkol; 2006; 50(2):127-35. PubMed ID: 16888676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and cancer.
    Vigneri P; Frasca F; Sciacca L; Pandini G; Vigneri R
    Endocr Relat Cancer; 2009 Dec; 16(4):1103-23. PubMed ID: 19620249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischaemic heart disease as an effect of obesity-related metabolic disturbances.
    Indulski JA; Lutz W
    Cent Eur J Public Health; 1999 Aug; 7(3):122-9. PubMed ID: 10499142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: steatosis, the metabolic syndrome and cancer.
    Bugianesi E
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():40-3. PubMed ID: 16225471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic complications of obesity in childhood and adolescence: more than just diabetes.
    Nathan BM; Moran A
    Curr Opin Endocrinol Diabetes Obes; 2008 Feb; 15(1):21-9. PubMed ID: 18185059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic medications: metabolic and cardiovascular risk.
    Newcomer JW
    J Clin Psychiatry; 2007; 68 Suppl 4():8-13. PubMed ID: 17539694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus type 2 - an independent risk factor for cancer?
    Grote VA; Becker S; Kaaks R
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):4-8. PubMed ID: 20127570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.
    Giovannucci E; Michaud D
    Gastroenterology; 2007 May; 132(6):2208-25. PubMed ID: 17498513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, insulin resistance and kidney disease risk: insights into the relationship.
    Sarafidis PA
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological aspects of neoplasms in diabetes.
    Nicolucci A
    Acta Diabetol; 2010 Jun; 47(2):87-95. PubMed ID: 20376506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, type 2 diabetes and risk of digestive cancer.
    Hillon P; Guiu B; Vincent J; Petit JM
    Gastroenterol Clin Biol; 2010 Oct; 34(10):529-33. PubMed ID: 20864282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thrifty 'catch-up fat' phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome.
    Dulloo AG; Jacquet J; Seydoux J; Montani JP
    Int J Obes (Lond); 2006 Dec; 30 Suppl 4():S23-35. PubMed ID: 17133232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and chronic kidney disease.
    Guarnieri G; Zanetti M; Vinci P; Cattin MR; Pirulli A; Barazzoni R
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S19-23. PubMed ID: 20797564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
    Ahmed I; Goldstein BJ
    Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low physical activity and obesity: causes of chronic disease or simply predictors?
    Telford RD
    Med Sci Sports Exerc; 2007 Aug; 39(8):1233-40. PubMed ID: 17762355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.